Burden of aspergillosis-related hospitalizations in the United States
- PMID: 11096031
- DOI: 10.1086/317487
Burden of aspergillosis-related hospitalizations in the United States
Erratum in
- Clin Infect Dis 2001 Feb 15;32(4):673
Abstract
In the United States in 1996, there were an estimated 10,190 aspergillosis-related hospitalizations (95% confidence interval [CI], 9000-11,380); these resulted in 1970 deaths (95% CI, 1659-2280), 176,272 hospital days (95% CI, 147,163-206,275), and $633.1 million in costs (95% CI, $492.0-$780.2 million). The average hospitalization lasted 17.3 days (95% CI, 16.1-18.6) and cost $62,426 (95% CI, $52,670-$72,181). Although aspergillosis-related hospitalizations account for a small percentage of hospitalizations in the United States, patients hospitalized with the condition have lengthy hospital stays and high mortality rates.
Similar articles
-
Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura.Am J Hematol. 2009 Oct;84(10):631-5. doi: 10.1002/ajh.21500. Am J Hematol. 2009. PMID: 19705429
-
Factors associated with hospital length of stay and hospital charges of motor vehicle crash related hospitalizations among children in the United States.Arch Pediatr Adolesc Med. 2007 Sep;161(9):889-95. doi: 10.1001/archpedi.161.9.889. Arch Pediatr Adolesc Med. 2007. PMID: 17768290
-
Burden of encephalitis-associated hospitalizations in the United States, 1988-1997.Clin Infect Dis. 2002 Jul 15;35(2):175-82. doi: 10.1086/341301. Epub 2002 Jun 21. Clin Infect Dis. 2002. PMID: 12087524
-
Hospitalizations for arthritis and other rheumatic conditions: data from the 1997 National Hospital Discharge Survey.Med Care. 2003 Dec;41(12):1367-73. doi: 10.1097/01.MLR.0000100582.52451.AC. Med Care. 2003. PMID: 14668669
-
Direct medical costs of syncope-related hospitalizations in the United States.Am J Cardiol. 2005 Mar 1;95(5):668-71. doi: 10.1016/j.amjcard.2004.11.013. Am J Cardiol. 2005. PMID: 15721118
Cited by
-
Fungal infections: their diagnosis and treatment in transplant recipients.Int J Hepatol. 2012;2012:106923. doi: 10.1155/2012/106923. Epub 2012 Aug 26. Int J Hepatol. 2012. PMID: 22966464 Free PMC article.
-
Epidemiological and Genomic Landscape of Azole Resistance Mechanisms in Aspergillus Fungi.Front Microbiol. 2016 Sep 21;7:1382. doi: 10.3389/fmicb.2016.01382. eCollection 2016. Front Microbiol. 2016. PMID: 27708619 Free PMC article. Review.
-
Combination treatment of invasive fungal infections.Clin Microbiol Rev. 2005 Jan;18(1):163-94. doi: 10.1128/CMR.18.1.163-194.2005. Clin Microbiol Rev. 2005. PMID: 15653825 Free PMC article. Review.
-
Salvage combination antifungal therapy for acute invasive aspergillosis may improve outcomes: a systematic review and meta-analysis.Int J Infect Dis. 2014 Nov;28:80-94. doi: 10.1016/j.ijid.2014.07.007. Epub 2014 Sep 18. Int J Infect Dis. 2014. PMID: 25240416 Free PMC article.
-
Utilization and comparative effectiveness of caspofungin and voriconazole early after market approval in the U.S.PLoS One. 2014 Jan 10;9(1):e83658. doi: 10.1371/journal.pone.0083658. eCollection 2014. PLoS One. 2014. PMID: 24427277 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical